|
|
EY-01Y4216
|
cis-N-Acetyl-S-(4-hydroxy-2-buten-1-yl)-L-cysteine (Contain up to 10% trans isomer)
|
|
5mg、50mg
|
￥0.0
|
|
|
|
EY-01Y4639
|
cis-5,8,11,14,17-Eicosapentaenoic acid, 95%
|
10417-94-4
|
25MG、100MG
|
￥0.0
|
|
|
|
EY-01Y3633
|
cis-4-Hydroxy-L-proline, 98%, for bio
|
618-27-9
|
1G、5G、250MG、50MG
|
￥0.0
|
|
|
|
EY-01Y3630
|
cis-4-Hydroxy-D-proline, 95%, for bio
|
2584-71-6
|
1G、5G、25G
|
￥0.0
|
|
|
|
EY-01Y4467
|
1,1-Cyclobutanedicarboxylatodiammineplatinum
|
41575-94-4
|
250MG、1G、5G
|
￥0.0
|
|
|
|
EY-01Y3670
|
2-Phthalimidino-glutaric acid
|
6349-98-0
|
5G、25G
|
￥0.0
|
|
|
|
EY-01Y4512
|
Carbenicillin-Na2-salt research grade
|
4800-94-6
|
5G
|
￥0.0
|
|
|
|
EY-01Y4962
|
Glycidyl propargyl ether, 97%
|
18180-30-8
|
1G、5G
|
￥0.0
|
|
|
|
EY-01Y4381
|
Carboplatin, 98%, a DNA synthesis inhibitor which binds to DNA, inhibits replication and transcription and induces cell death
|
41575-94-4
|
100MG
|
￥0.0
|
|
|
|
EY-01Y4792
|
Potassium tetraoxalate dihydrate, 98.5%
|
6100-20-5
|
25G、100G、500G、1KG
|
￥0.0
|
|
|
|
EY-01Y3529
|
Glycylglycylglycylglycine
|
637-84-3
|
1G、100MG
|
￥0.0
|
|
|
|
EY-01Y5034
|
Sodium tetraborate decahydrate, 99.5%, for analysis,PH:9.0 - 9.5 (5% soln.at 25 ℃)
|
1303-96-4
|
100G、1KG、5KG
|
￥0.0
|
|
|
|
EY-01Y4519
|
Tetracycline-HCl research grade
|
64-75-5
|
100G
|
￥0.0
|
|
|
|
EY-01Y4383
|
Tetracycline hydrochloride, 98%
|
64-75-5
|
25G、100G
|
￥0.0
|
|
|
|
EY-01Y4620
|
Tetracycline hydrochloride, 96%
|
64-75-5
|
25g、100g
|
￥0.0
|
|
